VICL (Vical Labs) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Scott H. Davis who wrote (1206)	2/14/2000 9:01:00 PM
From: Scott H. Davis	Read Replies (1) of 1972

Looks like they're rolling the dice with the high risk/reward option of going it alone with their current therapeutics <<but we now have the financial wherewithal to step up our manufacturing and marketing preparations to support the potential launch of our lead product candidate, Allovectin-7 for metastatic melanoma, and to advance selected research and development projects.>> With unpartnered therapeutics, I was wondering if they were unpartnered due to lack of interest, marginal data, or if it was their intent. Starting to look like the latter. Let's hope they have the expertise to work with the FDA successfully in the approval process. IMSCO Scott

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next